在心力衰竭中,更加重视肥胖试验
Josephine Harrington1,2, Naveed Sattar3, G Michael Felker4,5
1Division of Cardiology, Department of Internal Medicine, Duke University Medical Center, Durham, NC, USA. josephine.harrington@duke.edu.
Current heart failure reports
|April 15, 2024
概括
减肥药物,如塞马格卢提德,有望改善心力衰竭症状和健康状况. 目前正在进行的试验将进一步研究这些治疗方法,用于更广泛的心力衰竭患者群体.
科学领域:
- 心脏病学 心脏病学
- 代谢疾病 代谢疾病
- 临床试验 临床试验
背景情况:
- 心力衰竭 (HF) 是一个重要的全球健康负担.
- 肥胖是HF患者常见的并发症,影响预后.
- 有效的体重管理策略对于HF护理至关重要.
研究的目的:
- 审查目前和即将到来的临床试验,重点关注心力衰竭或高风险人群的减肥干预措施.
- 综合了关于减肥治疗在HF患者群体中的疗效的研究结果.
主要方法:
- 对正在进行和计划中的临床试验进行系统审查.
- 从研究药理减肥剂 (例如,西马格卢提德,蒂尔泽帕提德) 的试验中分析数据.
- 评估临床结果,包括减肥,健康状况 (KCCQ-CSS) 和功能能力 (6分钟步行测试).
主要成果:
- 塞马格卢提德在HF患者中显示显著的体重减轻和改善健康状况 (KCCQ-CSS) HF与保存的喷射分数 (HFpEF) 和肥胖.
- 随着塞马格卢提德治疗,观察到6分钟步行测试的改善.
- 目前正在进行的试验正在扩大研究范围,以包括心力衰竭中喷射小部分的全谱.
结论:
- 蓄意减肥,特别是使用诸如塞马格卢提德之类的药物,为控制心力衰竭中的肥胖提供了有前途的治疗途径.
- 需要进一步的研究来确定减肥干预措施在所有HF表型中的作用.
- 未来的试验将阐明新型减肥疗法在心力衰竭管理中的长期益处和安全性.
相关概念视频
Heart Failure Drugs: β-Blockers
337
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
337
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
422
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
422
Heart Failure Drugs: Diuretics
370
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
370
Exercise and Cardiovascular Response
797
Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
797
Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K


